Globus Medical (GMED)
(Delayed Data from NYSE)
$73.43 USD
+0.80 (1.10%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $73.40 -0.03 (-0.04%) 4:50 PM ET
1-Strong Buy of 5 1
C Value B Growth D Momentum C VGM
Price, Consensus and EPS Surprise
GMED 73.43 +0.80(1.10%)
Will GMED be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for GMED based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for GMED
Inspire Medical's (INSP) Inspire Therapy Gets CE Mark Approval
Globus Medical (GMED) Global Sales, Innovation Aid Growth
GMED: What are Zacks experts saying now?
Zacks Private Portfolio Services
Intuitive Surgical (ISRG) Q2 Earnings Beat, Procedures Robust
Intuitive Surgical (ISRG) Gains 26% Year to Date: Here's Why
Abbott (ABT) Q2 Earnings Surpass Estimates, Margins Expand
Other News for GMED
GMED Crosses Above Average Analyst Target
Buy Recommendation for Globus Medical Amidst Strategic Orthopedic Advances and Market Expansion
Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
Globus Medical receives FDA 510k clearance for ExcelsiusFlex, ACTIFY
Globus Medical gets FDA approval for two knee replacement products